|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/454 | (2006.01) | ||
| A61P 5/06 | (2006.01) |
| (11) | Number of the document | 2298760 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10185517.9 |
| Date of filing the European patent application | 2005-06-22 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 583757 P | 2004-06-29 | US |
| (72) |
Lorimer, Keith, US
Pines, Seemon, H., US
Paul, Bernhard, US
Littler, Benjamin, US
|
| (73) |
Helsinn Healthcare S.A.,
Via Pian Scairolo, 9, 6912 Lugano / Pazzallo,
CH
|
| (54) | Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |